Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of AESCITAM 20 mg vs Lexapro 20 mg in healthy Thai volunteers (fasting)
TCTR20210316002Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of escitalopram in major depressive disorder (MDD) (2 arms), sponsored by International Bio Service. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on TCTR20210316002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210316002.